Nexium (Esomeprazole)

Esomeprazole inhibits the H+/K+ ATPase enzyme, also known as the gastric proton pump, located on the surface of parietal cells in the stomach. This irreversible blockade stops the final step of acid secretion, leading to a sustained increase in gastric pH and allowing ulcerated tissue to heal.

The specific dose and infusion rate of Nexium injection are determined by the prescribing clinician based on the patient’s condition, severity, and renal or hepatic function. Healthcare professionals follow local guidelines and product labeling to set the appropriate regimen.

The safety of esomeprazole in pregnancy and lactation has not been definitively established. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To request Nexium, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and necessary import documentation.

Esomeprazole is the S‑enantiomer of omeprazole, offering more consistent plasma concentrations and potentially faster acid suppression. Compared with other PPIs, it may provide slightly higher bioavailability, but clinical outcomes are generally similar across the class when used at approved doses.

Nexium injection should be stored refrigerated at 2‑8 °C. Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking the solution. Do not use the product if it has been exposed to temperatures outside this range.

Nexium is supplied as an injectable solution for intravenous infusion. It is administered by a healthcare professional, typically diluted in an appropriate IV fluid and infused over a specified period, following the prescribing information and institutional protocols.

Serious risks include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated diarrhea, low magnesium levels leading to cardiac arrhythmias, and rare cases of acute interstitial nephritis. Patients should be monitored for these events, especially during prolonged therapy.

Nexium is contraindicated in patients with known hypersensitivity to esomeprazole, other proton pump inhibitors, or any component of the formulation. Caution is also advised for individuals with severe liver disease, certain drug interactions, or those who are pregnant or breastfeeding without clear medical justification.